Marshall Wace North America’s LivePerson LPSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.9M Buy
2,151
+1,703
+380% +$1.61M 0.01% 741
2021
Q2
$425K Buy
+448
New +$378K ﹤0.01% 1209
2021
Q1
Sell
-2,420
Closed -$2.26M 1659
2020
Q4
$2.26M Buy
+2,420
New +$2.08M 0.01% 725
2019
Q3
Sell
-1,496
Closed -$629K 1432
2019
Q2
$629K Buy
+1,496
New +$638K ﹤0.01% 847
2018
Q3
Sell
-31,720
Closed -$10M 1166
2018
Q2
$10M Buy
31,720
+29,876
+1,620% +$8.45M 0.06% 333
2018
Q1
$452K Sell
1,844
-267
-13% -$53.4K ﹤0.01% 1171
2017
Q4
$364K Buy
+2,111
New +$395K ﹤0.01% 1204
2013
Q4
$291K Buy
+1,310
New +$217K 0.01% 601

Other funds holding LPSN

Marshall Wace North America's LPSN Position: Q3 2021 in Review

Marshall Wace North America increased its LivePerson (LPSN) stake by 380% in Q3 2021, buying an estimated $1.61M and bringing the position to 2,151 shares worth $1.9M. The position accounts for 0.01% of the portfolio, ranked #741.

Marshall Wace North America first reported a position in LPSN in Q4 2013 and has held it in 8 quarters since. The position peaked at $10M in Q2 2018. 250 funds tracked by Wall St. Rank hold LPSN as of Q3 2021.

  • Marshall Wace North America held 2,151 shares of LivePerson worth $1.9M as of Q3 2021.
  • Marshall Wace North America bought 1,703 LivePerson shares in Q3 2021, an estimated $1.61M.
  • LivePerson made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #741 holding.
  • Marshall Wace North America first reported a position in LivePerson in Q4 2013 and has held it in 8 quarters since.
  • Marshall Wace North America's LivePerson position peaked at $10M in Q2 2018.
  • 250 funds tracked by Wall St. Rank held LivePerson as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.